Most tumors express high levels of this ECM glycoprotein and gliomas in particular have an enrichment of Tenascin-C (TN-C), which participates in tumor progression and correlates with tumor malignancy (204, 205). The gene discussed is TNC; the disease is central nervous system cancer.